Hedge Fund Drops Million in Crinetics: Is It a Buy?
A major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
Explore actionable methods to keep spending in check and align it with your budget. This intro provides simple, repeatable practices for effective management.
17,183 articlesA major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
Could short squeeze coming for Plug Power stock be the catalyst investors have been waiting for? This article breaks ...
A clear, investor-friendly look at Iridex's Q1 2026 performance and what it could mean for the full year. Learn the n...
Geopolitics can swing oil prices quickly. If Iran talks progress, the market could move fast. This guide shows practi...
IonQ stands at the crossroads of hype and real-world adoption in quantum computing. This ionq stock analysis: sell pi...
Rate Insurance's 2026 Trends Report shows 2025 home premiums rose 9.16%, the first notable slowdown after years of do...
Fannie Mae updates its crypto mortgage framework with a 250% collateral requirement, reshaping how crypto assets can ...
A fresh briefing from the Joint Economic Committee shows Medicare Advantage overpayments totaling about $7 billion pe...
Institutional moves can quietly reshape a stock's risk and reward. This article looks at Levin's trim of O-I Glass an...
Two leaders, two paths: Nuscale Power’s SMRs and Nano Nuclear Energy’s microreactors. This guide breaks down commerci...
A big strategic shift from Lilly could redefine how investors view weight-loss drugs. This article breaks down what h...
BlackRock’s bitcoin move was driven by client redemptions tied to ETF outflows, not a shift in the long-term crypto t...